company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24197700000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24197700000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6140700000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6140700000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18057000000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7556700000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4882800000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,327100000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4850000000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17616600000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,440400000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2976500000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75200000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3051700000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3492100000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,95300000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3396800000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3396800000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,121400000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3275400000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2169100000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.51
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2198300000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.49
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2169100000.0
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.51
Merck & Co Inc,MRK,,0000310158,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 07:33:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23850000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23850000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5583000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5583000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18267000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7377000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4805000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1033000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13215000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5052000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2561000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2318000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4879000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9931000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1999000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7932000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7932000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,124000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7808000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2136000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.65
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2136000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.63
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2136000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.65
Merck & Co Inc,MRK,,0000310158,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 08:05:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4576000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4576000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1737000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1737000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2839000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1660000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,893000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,101000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2654000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,185000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,434000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,473000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,658000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,614000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,614000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,38000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,576000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1645700000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1645700000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1645700000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Merck & Co Inc,MRK,,0000310158,2008.0,Q3,2008-07-01,2008-09-30,2009-10-29 16:33:24+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.065
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4921000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4921000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1908000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1908000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3013000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1870000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,906000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,94000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2870000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,143000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,493000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-134000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,359000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,502000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,462000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,462000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,38000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,424000000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1630800000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1630800000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1630800000.0
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Merck & Co Inc,MRK,,0000310158,2008.0,Q2,2008-04-01,2008-06-30,2009-07-24 16:45:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.065
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27428000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27428000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9019000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9019000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18409000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8543000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5845000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1634000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16022000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2387000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2235000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10668000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12903000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15290000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13022000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13022000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,123000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12899000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.67
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.65
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.67
Merck & Co Inc,MRK,,0000310158,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 13:09:51+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10093200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10093200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4901000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4901000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5192200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3455100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1971500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1489900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6916500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1724300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,373900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7813300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8187200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6462900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-59700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6522600000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6522600000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6493400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.64
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.63
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2268000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.64
Merck & Co Inc,MRK,,0000310158,2009.0,Q4,2009-10-01,2009-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17334800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17334800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4118000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4118000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13216800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5087900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3873500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,144100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9105500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4111300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1861100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2854700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4715800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8827100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2327700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6499400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6499400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,93800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6405600000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2109100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.03
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2109100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.02
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2109100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.03
Merck & Co Inc,MRK,,0000310158,2009.0,Q3YTD,2009-01-01,2009-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6049700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6049700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1430300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1430300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4619400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1725500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1254000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,42400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3021900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1597500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,688200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2791100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3479300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5076800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1621500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3455300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3455300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3424300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2109100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2109100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2109100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
Merck & Co Inc,MRK,,0000310158,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 07:47:43+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11285100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11285100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2687700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2687700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8597400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3362400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2619500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,101700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6083600000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2513800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1172900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,63600000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1236500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3750300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,706200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3044100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3044100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,62800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2981300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2108700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.41
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2108700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2108700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.41
Merck & Co Inc,MRK,,0000310158,2009.0,Q2YTD,2009-01-01,2009-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.76
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5899900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5899900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1353900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1353900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4546000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1729500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1395300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,37400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3162200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1383800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,587100000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3600000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,583500000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1967300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,379000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1588300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1588300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1556300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2108700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2108700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2108700000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Merck & Co Inc,MRK,,0000310158,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:24:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5385200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5385200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1333800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1333800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4051400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1632900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1224200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,64300000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2921400000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1130000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,585800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,67200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,653000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1783000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,327200000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1455800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1455800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,30800000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1425000000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2126900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2126900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2126900000.0
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Merck & Co Inc,MRK,,0000310158,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 08:20:51+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12094000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12094000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4440000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4440000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7654000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3536000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4559000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,121000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8216000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-562000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,170000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-310000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-140000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-702000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-202000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-500000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-500000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-532000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3075000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3075000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3075000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Merck & Co Inc,MRK,,0000310158,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45987000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45987000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18396000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18396000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27591000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13125000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11111000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,985000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25221000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2370000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,587000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1304000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-717000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1653000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,671000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,982000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,982000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,121000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,861000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3075000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3075000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3075000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Merck & Co Inc,MRK,,0000310158,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:54:26+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33893000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33893000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13956000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13956000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19937000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9589000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6552000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,864000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17005000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2932000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,417000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-994000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-577000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2355000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,873000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1482000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1482000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,89000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1393000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Merck & Co Inc,MRK,,0000310158,2010.0,Q3YTD,2010-01-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43986200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43986200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18857000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18857000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25129200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13044100000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8523500000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2353900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23921500000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1207700000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,790900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6819300000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7610200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8817900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,813300000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8004600000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8004600000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,118200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7886400000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.09
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.07
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.09
Merck & Co Inc,MRK,,0000310158,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11125000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11125000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4191000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4191000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6934000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3192000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2322000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,50000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5564000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1370000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,236000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1108000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-872000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,498000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,126000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,372000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,372000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,30000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,342000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3078000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Merck & Co Inc,MRK,,0000310158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:12:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22768000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22768000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9765000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9765000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13003000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6397000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4230000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,814000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11441000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1562000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,181000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,114000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,295000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1857000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,747000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1110000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1110000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,59000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1051000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2010.0,Q2YTD,2010-01-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.76
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38910900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38910900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16096300000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16096300000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22814600000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11577600000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7455500000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2346300000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21379400000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1435200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1243100000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10718400000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11961500000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13396700000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2308800000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11087900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11087900000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,119200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10968700000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.6
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.57
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.6
Merck & Co Inc,MRK,,0000310158,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11346000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11346000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4549000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4549000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6797000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3175000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2179000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,526000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5880000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,917000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,281000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,324000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1241000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,461000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,780000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,780000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,752000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3105000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Merck & Co Inc,MRK,,0000310158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 07:43:43+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33464800000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33464800000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12901200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12901200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20563600000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10132100000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6671800000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1857700000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18661600000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1902000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1787200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10433800000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12221000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14123000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2226800000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11896200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11896200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,123200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11773000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3114000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.1
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3322200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.07
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3114000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.1
Merck & Co Inc,MRK,,0000310158,2010.0,Q1TTM,2009-04-01,2010-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11422000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11422000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5216000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5216000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6206000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3222000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2051000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,288000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5561000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,645000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-167000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,616000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,286000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,330000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,330000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,299000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3114000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3322200000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3114000000.0
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Merck & Co Inc,MRK,,0000310158,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:58:35+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12294000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12294000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4176000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4176000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8118000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3704000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2419000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,533000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6656000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1462000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,256000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-137000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,119000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1581000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1543000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1543000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,30000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1513000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Merck & Co Inc,MRK,,0000310158,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48047000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48047000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16871000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16871000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31176000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13733000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8467000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1306000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23506000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7670000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,610000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-946000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-336000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7334000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,942000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6392000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6392000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,120000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6272000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.02
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Merck & Co Inc,MRK,,0000310158,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:59:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.56
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35753000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35753000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12695000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12695000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23058000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10029000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6048000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,773000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16850000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6208000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,354000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-809000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-455000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5753000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,904000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4849000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4849000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,90000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4759000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.54
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.54
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.54
Merck & Co Inc,MRK,,0000310158,2011.0,Q3YTD,2011-01-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47847000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47847000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17135000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17135000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30712000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13565000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10607000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,894000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25066000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5646000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,524000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1119000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-595000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5051000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,702000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4349000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4349000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,122000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4227000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.37
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.38
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.37
Merck & Co Inc,MRK,,0000310158,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12022000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12022000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4352000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4352000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7670000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3340000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1954000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,119000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5413000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2257000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,161000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-66000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,95000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2352000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,628000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1724000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1724000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1692000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3070000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:02:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23731000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23731000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8343000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8343000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15388000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6689000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4094000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,654000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11437000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3951000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,193000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-743000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-550000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3401000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,276000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3125000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3125000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,58000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3067000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.99
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.99
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.99
Merck & Co Inc,MRK,,0000310158,2011.0,Q2YTD,2011-01-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.76
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46950000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46950000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16974000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16974000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29976000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13417000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10975000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,825000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25217000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4759000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,599000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2161000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1562000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3197000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2997000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2997000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,120000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2877000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Merck & Co Inc,MRK,,0000310158,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12151000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12151000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4284000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4284000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7867000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3525000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1936000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,668000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6129000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1738000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-121000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-66000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1672000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-382000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2054000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2054000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,30000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2024000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3086000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Merck & Co Inc,MRK,,0000310158,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 17:05:43+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46145000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46145000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17239000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17239000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28906000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13067000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11218000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,683000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24968000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3938000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,587000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1759000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1172000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2766000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1043000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1723000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1723000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,118000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1605000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3084000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3084000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3084000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Merck & Co Inc,MRK,,0000310158,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11580000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11580000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4059000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4059000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7521000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3164000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2158000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-14000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5308000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2213000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-622000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-484000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1729000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,658000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1071000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1043000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3084000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3084000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3084000000.0
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 07:40:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47267000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47267000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16446000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16446000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30821000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12776000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8168000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,664000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21608000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9213000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,642000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1116000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-474000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8739000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2440000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6299000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6299000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,131000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6168000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
Merck & Co Inc,MRK,,0000310158,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 14:02:50+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.69
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11737000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11737000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4160000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4160000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7577000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3390000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2223000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,191000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5804000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1773000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,232000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-671000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-439000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1334000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,385000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,949000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,949000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,41000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,908000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Merck & Co Inc,MRK,,0000310158,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35530000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35530000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12286000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12286000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23244000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9386000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5945000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,473000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15804000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7440000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,410000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-445000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7405000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2055000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5350000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5350000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,90000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5260000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.73
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.7
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.73
Merck & Co Inc,MRK,,0000310158,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.26
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47824000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47824000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16462000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16462000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31362000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13090000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8364000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1006000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22460000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8902000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,666000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-582000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,84000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8986000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2093000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6893000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6893000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,120000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6773000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.23
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.18
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.23
Merck & Co Inc,MRK,,0000310158,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.68
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11488000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11488000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4137000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4137000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7351000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3063000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1918000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,110000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5091000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2260000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,158000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-200000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-42000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2218000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,455000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1763000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1763000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,34000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1729000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3045000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Merck & Co Inc,MRK,,0000310158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:59:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24042000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24042000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8149000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8149000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15893000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6323000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4027000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,363000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10713000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5180000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,252000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-245000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5187000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3587000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3587000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,56000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3531000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Merck & Co Inc,MRK,,0000310158,2012.0,Q2YTD,2012-01-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.84
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48358000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48358000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16677000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16677000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31681000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13367000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8400000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1015000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22782000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8899000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,669000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-448000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,221000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9120000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2266000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6854000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6854000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,118000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6736000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.21
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.17
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.21
Merck & Co Inc,MRK,,0000310158,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.64
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12311000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12311000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4112000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4112000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8199000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3249000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2165000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,144000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5558000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2641000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,142000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-103000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,39000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2680000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,860000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1820000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1820000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,27000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1793000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3041000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Merck & Co Inc,MRK,,0000310158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48198000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48198000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16849000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16849000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31349000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13643000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8171000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1539000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23353000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7996000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,582000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-466000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8112000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1024000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7088000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7088000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,121000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6967000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3043000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.27
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3043000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.24
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3043000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.27
Merck & Co Inc,MRK,,0000310158,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.6
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11731000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11731000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4037000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4037000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7694000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3074000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1862000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,219000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5155000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2539000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-142000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2507000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,740000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1767000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1767000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1738000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3043000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3043000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3043000000.0
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Merck & Co Inc,MRK,,0000310158,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:05:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44033000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44033000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16954000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16954000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27079000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11911000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7503000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1709000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21123000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5956000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-411000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-411000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5545000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1028000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4517000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4517000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,113000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4404000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2963000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2963000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2963000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
Merck & Co Inc,MRK,,0000310158,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 16:04:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.73
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11320000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11320000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4607000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4607000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6713000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2981000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1835000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,565000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5381000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1332000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-351000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,244000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-107000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1225000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,409000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,816000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,816000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,35000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,781000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2963000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2963000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2963000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Merck & Co Inc,MRK,,0000310158,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32713000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32713000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12347000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12347000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20366000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8930000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5668000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1144000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15742000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4624000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,351000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-655000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-304000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4320000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,619000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3701000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3701000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,78000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3623000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Merck & Co Inc,MRK,,0000310158,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.29
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44450000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44450000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16507000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16507000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27943000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12320000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7891000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1335000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21546000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6397000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,583000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1326000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-743000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5654000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1004000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4650000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4650000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,119000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4531000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.51
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.51
Merck & Co Inc,MRK,,0000310158,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.72
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11032000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11032000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4104000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4104000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6928000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2803000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1660000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,870000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5333000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1595000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,102000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-172000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-70000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1525000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1150000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1150000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,26000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1124000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2927000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Merck & Co Inc,MRK,,0000310158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 07:50:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21681000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21681000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8243000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8243000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13438000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6127000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4008000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,274000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10409000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3029000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,249000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-483000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-234000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2795000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,244000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2551000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2551000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,52000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2499000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Merck & Co Inc,MRK,,0000310158,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.86
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44906000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44906000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16540000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16540000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28366000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12580000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8149000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,575000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21304000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7062000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,639000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1354000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-715000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6347000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1084000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5263000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5263000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,127000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5136000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.7
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.68
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.7
Merck & Co Inc,MRK,,0000310158,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.71
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11010000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11010000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4284000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4284000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6726000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3140000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2101000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,155000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5396000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1330000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-201000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-85000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1245000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,310000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,935000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,935000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,906000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2977000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Merck & Co Inc,MRK,,0000310158,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:04:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46207000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46207000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16368000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16368000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29839000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12689000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8213000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,564000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21466000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8373000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,665000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1256000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-591000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7782000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1634000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6148000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6148000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,125000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6023000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3022000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3022000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.96
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3022000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
Merck & Co Inc,MRK,,0000310158,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.7
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10671000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10671000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3959000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3959000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6712000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2987000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1907000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,119000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5013000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1699000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,133000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-282000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-149000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1550000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-66000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1616000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1616000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1593000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3022000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3022000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3022000000.0
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Merck & Co Inc,MRK,,0000310158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:35+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42237000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42237000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16768000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16768000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25469000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11606000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7180000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1013000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19799000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5670000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11613000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11613000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17283000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5349000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11920000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2894000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.12
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2894000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.07
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2894000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.12
Merck & Co Inc,MRK,,0000310158,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 16:33:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.77
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10482000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10482000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3749000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3749000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6733000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2924000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2283000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,349000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5556000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1177000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10634000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10634000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11811000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4483000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7328000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7328000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,12000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7316000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2894000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.54
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2894000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.51
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2894000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.54
Merck & Co Inc,MRK,,0000310158,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.45
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10557000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10557000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4223000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4223000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6334000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2975000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1659000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,376000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5010000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1324000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,166000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,166000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1490000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,648000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,842000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,842000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-53000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,895000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Merck & Co Inc,MRK,,0000310158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:32:00+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31755000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31755000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13019000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13019000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18736000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8682000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4897000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,664000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14243000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4493000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,979000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,979000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5472000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,866000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4606000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4606000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4604000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.58
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.56
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.58
Merck & Co Inc,MRK,,0000310158,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.32
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43075000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43075000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17626000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17626000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25449000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11663000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6732000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1229000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19624000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5825000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-351000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1223000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,872000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6697000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1275000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5422000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5422000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,37000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5385000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.86
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.83
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2879000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.86
Merck & Co Inc,MRK,,0000310158,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.76
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4893000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4893000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6041000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2973000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1664000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,163000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4800000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1241000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,650000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,650000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1891000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-142000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2033000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2033000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2004000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Merck & Co Inc,MRK,,0000310158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:17:10+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21198000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21198000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8796000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8796000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12402000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5707000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3238000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,288000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9233000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3169000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,813000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,813000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3982000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,218000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3764000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3764000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,55000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3709000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.88
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43550000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43550000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17507000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17507000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26043000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11491000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6733000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1723000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19947000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6096000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-249000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,885000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,636000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6732000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1002000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5730000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5730000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,116000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5614000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.93
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.9
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2917000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.93
Merck & Co Inc,MRK,,0000310158,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.75
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10264000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10264000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3903000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3903000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6361000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2734000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1574000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,125000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4433000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1928000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,163000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,163000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2091000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,360000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1731000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1731000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,26000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1705000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Merck & Co Inc,MRK,,0000310158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:34:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43626000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43626000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16898000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16898000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26728000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11658000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7170000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1715000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20543000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6185000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-133000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-99000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6086000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1454000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4632000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4632000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,116000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4516000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.54
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2934000000.0
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.54
Merck & Co Inc,MRK,,0000310158,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.74
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39498000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39498000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14934000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14934000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24564000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10313000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6704000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,619000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17636000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6928000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1527000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1527000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5401000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,942000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4459000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4459000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,17000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4442000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.58
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.56
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.58
Merck & Co Inc,MRK,,0000310158,2015.0,FY,2015-01-01,2015-12-31,2018-02-27 16:33:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.81
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10215000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10215000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3850000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3850000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6365000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2616000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1797000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,233000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4646000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1719000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-903000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-903000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-166000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,982000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,982000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,976000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Merck & Co Inc,MRK,,0000310158,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10073000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10073000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3761000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3761000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6312000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2472000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1500000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,113000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4085000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2227000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,170000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,170000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2397000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,566000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1831000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1831000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Merck & Co Inc,MRK,,0000310158,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:19:24+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.45
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29283000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29283000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11084000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11084000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18199000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7697000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4907000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,386000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12990000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5209000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-624000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-624000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4585000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1108000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3477000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3477000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3466000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.23
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.21
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.23
Merck & Co Inc,MRK,,0000310158,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.35
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39765000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39765000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14833000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14833000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24932000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10621000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7190000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,735000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18546000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6386000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10010000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10010000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16396000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5591000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10805000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10805000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10782000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.77
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.72
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2814000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.77
Merck & Co Inc,MRK,,0000310158,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.8
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9785000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9785000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3754000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3754000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6031000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2624000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1670000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,191000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4485000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1546000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-739000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-739000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,807000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,119000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,688000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,688000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,687000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Merck & Co Inc,MRK,,0000310158,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:37:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.45
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19210000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19210000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7323000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7323000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11887000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5225000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3407000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,273000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8905000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2982000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-794000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-794000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2188000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,542000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1646000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1646000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1640000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Merck & Co Inc,MRK,,0000310158,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.9
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40249000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40249000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15295000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15295000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24954000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11124000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7349000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,998000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19471000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5483000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10006000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10006000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15489000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5673000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9816000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-35000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9851000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.43
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.39
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2826000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.43
Merck & Co Inc,MRK,,0000310158,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.79
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9425000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9425000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3569000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3569000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5856000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2601000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1737000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,82000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4420000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1436000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-55000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-55000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1381000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,423000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,958000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,958000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,953000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2835000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2835000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2835000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Merck & Co Inc,MRK,,0000310158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:32:41+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.45
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41398000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41398000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16434000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16434000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24964000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11473000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7343000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,970000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19786000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5178000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11395000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11395000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16573000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5412000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11161000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11161000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11168000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2835000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.88
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2835000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.83
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2835000000.0
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.88
Merck & Co Inc,MRK,,0000310158,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.78
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39807000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39807000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14030000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14030000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25777000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10017000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10261000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,651000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20929000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4848000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-189000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-189000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4659000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,718000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3941000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3941000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3920000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2766000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.42
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2766000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2766000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.42
Merck & Co Inc,MRK,,0000310158,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:36:42+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.85
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10115000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10115000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3471000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3471000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6644000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2848000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4787000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,265000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7900000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1256000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-100000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1356000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-770000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-586000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-586000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-594000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2766000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2766000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2766000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Merck & Co Inc,MRK,,0000310158,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10536000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10536000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3409000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3409000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7127000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2393000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1664000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,161000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4218000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2909000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2887000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,699000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2188000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2188000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2184000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.79
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.79
Merck & Co Inc,MRK,,0000310158,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:38:23+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29692000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29692000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10559000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10559000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19133000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7169000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5474000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,386000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13029000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6104000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-89000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-89000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6015000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1488000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4527000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4527000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,13000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4514000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
Merck & Co Inc,MRK,,0000310158,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.38
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39907000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39907000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14409000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14409000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25498000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9785000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7271000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,619000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17675000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7823000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-992000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-992000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6831000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1322000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5509000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5509000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,19000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5490000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.96
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2765000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
Merck & Co Inc,MRK,,0000310158,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.84
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9844000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9844000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3578000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3578000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6266000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2458000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2151000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,134000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4743000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1523000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1504000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,295000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1209000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1209000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1205000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Merck & Co Inc,MRK,,0000310158,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:39:40+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19156000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19156000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7150000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7150000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12006000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4776000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3810000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,225000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8811000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3195000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-67000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-67000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3128000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,789000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2339000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2339000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2330000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Merck & Co Inc,MRK,,0000310158,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.92
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39444000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39444000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14761000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14761000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24683000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9864000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7107000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,571000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17542000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7141000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-800000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6341000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1189000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5152000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5152000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5132000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.82
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2768000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
Merck & Co Inc,MRK,,0000310158,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.83
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9312000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9312000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3572000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3572000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5740000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2318000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1659000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,91000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4068000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1672000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-48000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1624000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,494000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1130000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1130000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1125000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2774000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2774000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2774000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Merck & Co Inc,MRK,,0000310158,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:39:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39385000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39385000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14937000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14937000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24448000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10030000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6626000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,628000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17284000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7164000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1520000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1520000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5644000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1013000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4631000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4631000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,17000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4614000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2774000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2774000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.63
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2774000000.0
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
Merck & Co Inc,MRK,,0000310158,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.82
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40122000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40122000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12912000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12912000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27210000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10074000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10339000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,776000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21189000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6021000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,500000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6521000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4103000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2418000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2418000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2394000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Merck & Co Inc,MRK,,0000310158,2017.0,FY,2017-01-01,2017-12-31,2020-02-26 16:36:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.89
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10433000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10433000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3440000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3440000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6993000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2643000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2314000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,306000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5263000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,149000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,149000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1879000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2917000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1038000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1038000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1047000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2730000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Merck & Co Inc,MRK,,0000310158,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10325000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10325000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3307000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3307000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7018000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2459000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4413000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,153000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7025000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,207000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,207000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,200000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,251000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Merck & Co Inc,MRK,,0000310158,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:11+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29689000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29689000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9472000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9472000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20217000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7431000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8025000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,470000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15926000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4291000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,351000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,351000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4642000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1186000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3456000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3456000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,15000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3441000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.25
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
Merck & Co Inc,MRK,,0000310158,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.41
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39804000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39804000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12943000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12943000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26861000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10279000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12812000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,735000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23826000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3035000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,251000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,251000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3286000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,416000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2870000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2870000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2847000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.03
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2727000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.03
Merck & Co Inc,MRK,,0000310158,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.88
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9930000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9930000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3116000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3116000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6814000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2500000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1782000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,166000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4448000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2366000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,73000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,73000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2439000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,488000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1951000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1951000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1946000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.71
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.71
Merck & Co Inc,MRK,,0000310158,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:32:58+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19364000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19364000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6165000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6165000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13199000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4972000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3612000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,317000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8901000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4298000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,144000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,144000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4442000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,935000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3507000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3507000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,10000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3497000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.94
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40015000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40015000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13045000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13045000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26970000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10213000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10063000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,743000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21019000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5951000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5973000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,864000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5109000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5109000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,22000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5087000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.84
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.85
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2734000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.84
Merck & Co Inc,MRK,,0000310158,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.87
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9434000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9434000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3049000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3049000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6385000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2472000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1830000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,151000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4453000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1932000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,71000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,71000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2003000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,447000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1556000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1556000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1551000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2745000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2745000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2745000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Merck & Co Inc,MRK,,0000310158,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39929000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39929000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13507000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13507000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26422000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10171000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10432000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,711000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21314000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5108000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-70000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-70000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5038000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,671000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4367000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4367000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4346000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2745000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.57
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2745000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.57
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2745000000.0
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.57
Merck & Co Inc,MRK,,0000310158,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.86
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42294000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42294000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13509000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13509000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28785000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10102000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9752000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,632000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20486000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8299000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,402000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,402000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8701000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2508000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6193000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6193000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-27000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6220000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2664000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.34
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2664000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.32
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2664000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.34
Merck & Co Inc,MRK,,0000310158,2018.0,FY,2018-01-01,2018-12-31,2020-02-26 16:36:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.99
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10998000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10998000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3289000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3289000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7709000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2643000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2214000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,138000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4995000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2714000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-109000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-109000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2605000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,827000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1778000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1778000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-49000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1827000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2664000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2664000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2664000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Merck & Co Inc,MRK,,0000310158,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10794000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10794000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3619000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3619000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7175000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2443000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2068000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,171000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4682000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2493000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,172000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,172000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2665000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,707000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1958000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1958000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1950000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.73
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.73
Merck & Co Inc,MRK,,0000310158,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:43:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31296000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31296000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10220000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10220000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21076000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7459000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7538000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,494000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15491000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5585000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,511000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,511000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6096000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1681000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4415000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4415000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,22000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4393000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.63
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
Merck & Co Inc,MRK,,0000310158,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.44
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41729000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41729000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13660000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13660000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28069000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10102000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9852000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,800000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20754000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7315000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,660000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,660000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7975000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4598000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3377000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3377000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3346000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2662000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.92
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10465000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10465000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3417000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3417000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7048000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2508000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2274000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,228000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5010000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2038000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,48000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2086000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,370000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1716000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1716000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1707000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.64
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.64
Merck & Co Inc,MRK,,0000310158,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:34:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20502000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20502000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6601000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6601000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13901000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5016000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5470000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,323000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10809000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3092000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,339000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,339000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3431000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,974000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2457000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2457000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2443000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Merck & Co Inc,MRK,,0000310158,2018.0,Q2YTD,2018-01-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.96
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41260000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41260000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13348000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13348000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27912000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10118000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12197000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,782000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23097000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4815000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5510000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4142000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1368000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1368000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1340000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2683000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Merck & Co Inc,MRK,,0000310158,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.91
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10037000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10037000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3184000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3184000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6853000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2508000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3196000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,95000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5799000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1054000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,291000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,291000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1345000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,604000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,741000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,741000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,736000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Merck & Co Inc,MRK,,0000310158,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40725000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40725000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13047000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13047000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27678000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10110000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11705000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,720000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22535000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5143000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,720000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,720000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5863000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4260000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1603000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1603000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1579000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2695000000.0
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Merck & Co Inc,MRK,,0000310158,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.9
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11867000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11867000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3669000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3669000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8198000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2889000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2548000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,194000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5631000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2567000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,224000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,224000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2791000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,427000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2364000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2364000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2357000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2565000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2565000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.92
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2565000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Merck & Co Inc,MRK,,0000310158,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.61
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46840000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46840000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14112000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14112000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32728000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10615000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9872000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,638000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21125000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11603000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-139000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-139000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11464000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1687000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9777000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9777000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-66000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9843000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2565000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.84
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2565000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.81
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2565000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.84
Merck & Co Inc,MRK,,0000310158,2019.0,FY,2019-01-01,2019-12-31,2020-02-26 16:36:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.26
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34973000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34973000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10443000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10443000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24530000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7726000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7324000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,444000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15494000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9036000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-363000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-363000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8673000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1260000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7413000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7413000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-73000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7486000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.91
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.89
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.91
Merck & Co Inc,MRK,,0000310158,2019.0,Q3YTD,2019-01-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.65
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45971000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45971000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13732000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13732000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32239000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10369000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9538000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,582000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20489000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11750000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-472000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-472000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11278000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2087000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9191000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9191000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-122000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9313000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.61
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.58
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.61
Merck & Co Inc,MRK,,0000310158,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.2
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12397000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12397000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3990000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3990000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8407000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2589000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3204000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,232000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6025000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2382000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2347000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,440000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1907000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1907000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1901000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2558000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Merck & Co Inc,MRK,,0000310158,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:43:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22576000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22576000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6453000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6453000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16123000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5137000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4120000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,212000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9469000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6654000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-328000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-328000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6326000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,820000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5506000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5506000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-79000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.17
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.15
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.17
Merck & Co Inc,MRK,,0000310158,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.1
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44368000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44368000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13361000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13361000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31007000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10223000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8402000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,521000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19146000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11861000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-265000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-265000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11596000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2354000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9242000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9242000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-120000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9362000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.6
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.57
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.6
Merck & Co Inc,MRK,,0000310158,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.13
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11760000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11760000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3401000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3401000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8359000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2712000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2189000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,59000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4960000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3399000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-140000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-140000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3259000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,615000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2644000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2644000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2670000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.03
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2574000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Merck & Co Inc,MRK,,0000310158,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:34:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10816000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10816000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3052000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3052000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7764000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2425000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1931000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,153000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4509000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3255000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-188000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-188000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3067000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,205000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2862000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2862000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-53000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2915000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.13
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.12
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.13
Merck & Co Inc,MRK,,0000310158,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:36:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43073000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43073000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13377000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13377000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29696000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10019000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8487000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,690000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19196000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10500000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-77000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-77000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10423000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2109000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8314000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8314000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-85000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8399000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.2
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.17
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2585000000.0
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.2
Merck & Co Inc,MRK,,0000310158,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.06
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48081000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48081000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14372000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14372000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33709000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10745000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10150000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,557000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21452000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12257000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12235000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2101000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10134000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10134000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10147000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2533000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.98
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2533000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.95
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2533000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.98
Merck & Co Inc,MRK,,0000310158,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.32
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12057000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12057000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3312000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3312000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8745000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2555000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2209000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,72000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4836000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3909000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-71000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-71000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3838000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,619000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3219000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3219000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3219000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2533000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2533000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2533000000.0
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Merck & Co Inc,MRK,,0000310158,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 16:36:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.61
